Utama › Obesiti › Mississippi › Gulfport
Kajian klinikal Obesiti di Gulfport, MS
6 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar Gulfport (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Mengambil pesertaFasa 3
- Dynamed Clinical Research, LP d/b/a DM Clinical Research, Gulfport
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Mengambil pesertaFasa 3
- AURORA-2 Clinical Site, Gulfport
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Mengambil pesertaFasa 3
- AURORA-1 Clinical Site, Gulfport
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Mengambil pesertaFasa 3
- DelRicht Research at Gulfport Memorial, Gulfport
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
- ACCOMPLISH-2 Research Site, Gulfport
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Mengambil pesertaFasa 3
- ACCOMPLISH-1 Research Site, Gulfport
Kajian Obesiti di bandar lain
- Houston, TX43 kajian
- Chicago, IL41 kajian
- New York City, NY40 kajian
- San Antonio, TX40 kajian
- Washington, DC33 kajian
- Orlando, FL32 kajian
- Dallas, TX30 kajian
- Boston, MA28 kajian
- Las Vegas, NV27 kajian
- Miami, FL27 kajian
- Baltimore, MD26 kajian
- Jacksonville, FL25 kajian
Kajian lain di Gulfport
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.